SKLB-287, a Novel Oral Multikinase Inhibitor of EGFR and VEGFR2, Exhibits Potent Antitumor Activity in LoVo Colorectal Tumor Model
Neoplasma - Slovakia
doi 10.4149/neo_2014_063
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2014
Authors
Publisher
AEPress, s.r.o.